{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:43:11Z","timestamp":1761648191167},"reference-count":114,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.4155\/fmc.14.14","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T17:01:38Z","timestamp":1401901298000},"page":"657-674","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["The Design of Novel Classes of Macrolides for Neutrophil-Dominated Inflammatory Diseases"],"prefix":"10.1080","volume":"6","author":[{"given":"Vesna Erakovi\u0107","family":"Haber","sequence":"first","affiliation":[{"name":"Fidelta d.o.o., Prilaz baruna Filipovi\u0107a 29, HR-10000Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Bosnar","sequence":"additional","affiliation":[{"name":"Fidelta d.o.o., Prilaz baruna Filipovi\u0107a 29, HR-10000Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Kragol","sequence":"additional","affiliation":[{"name":"Fidelta d.o.o., Prilaz baruna Filipovi\u0107a 29, HR-10000Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3399"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072636"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073998"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-007-0071-6"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.04.002"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450111314020002"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1348463"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.12.020"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4089"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-013-0366-8"},{"key":"e_1_3_3_14_1","unstructured":"Y\u2019S Therapeutics Co Ltd: WO2009023196 (2009)."},{"key":"e_1_3_3_15_1","unstructured":"Zambon Group S.P.A.: WO2007003422 (2007)."},{"key":"e_1_3_3_16_1","unstructured":"GlaxoSmithKline Research Centre Zagreb d.o.o.: WO2006077501 (2006)."},{"key":"e_1_3_3_17_1","unstructured":"Basilea Pharmaceutica Ag.: WO2009098320 (2009)."},{"key":"e_1_3_3_18_1","unstructured":"Basilea Pharmaceutica Ag.: WO2011018510 (2011)."},{"key":"e_1_3_3_19_1","unstructured":"Zambon Group S.P.A.: WO2008072034 (2008)."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00292.2012"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.04.036"},{"key":"e_1_3_3_22_1","unstructured":"Glaxo Group Ltd: WO2011131749 (2011)."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm300356u"},{"key":"e_1_3_3_24_1","unstructured":"GlaxoSmithKline Research Centre Zagreb d.o.o.: WO2006087644 (2007)."},{"key":"e_1_3_3_25_1","unstructured":"GlaxoSmithKline Research Centre Zagreb d.o.o.: WO2010086349 (2010)."},{"key":"e_1_3_3_26_1","unstructured":"Merckle Gmbh.: WO2007012464 (2007)."},{"key":"e_1_3_3_27_1","unstructured":"GlaxoSmithKline Research Centre Zagreb d.o.o.: WO2006092739 (2006)."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.10.036"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2005.11"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1581-1585.2004"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2012.12.010"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-16"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/01902140802093238"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2007.10.006"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.04.004"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2012.51"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.02.013"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2012.02.005"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.08.009"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22620"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00840-10"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01123-09"},{"key":"e_1_3_3_43_1","unstructured":"ClinicalTrials Database: NCT01756339. www.clinicaltrials.gov\/show\/NCT01756339"},{"key":"e_1_3_3_44_1","unstructured":"ClinicalTrial Database: NCT01968733. www.clinicaltrials.gov\/ct2\/show\/NCT01968733"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06315.x"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/35101544"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(03)00022-4"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00570-1"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.07.013"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1008685107"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00860-10"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.185.14.4276-4279.2003"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.2.191"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg321"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.04.022"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000247109.44249.ac"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl014"},{"key":"e_1_3_3_58_1","first-page":"75","article-title":"Immunomodulatory effects of macrolide antibiotics \u2013 part 2: advantages and disadvantages of long-term, low-dose macrolide therapy","volume":"81","author":"Altenburg J","year":"2011","unstructured":"Altenburg J , DeGraaff CS, van Der WerfTS, BoersmaWG. Immunomodulatory effects of macrolide antibiotics \u2013 part 2: advantages and disadvantages of long-term, low-dose macrolide therapy. Respir. Int. Rev. Thorac. Dis.81, 75\u201387 (2011).","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2290"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104623"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202698"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002158"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252607699"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2007.2044"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176950"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-196"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.023"},{"issue":"4","key":"e_1_3_3_68_1","first-page":"379","article-title":"Prospective, comparative study (1994\u20131998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD","volume":"13","author":"G\u00f3mez J","year":"2000","unstructured":"G\u00f3mez J , Ba\u00f1osV, SimarroEet al. Prospective, comparative study (1994\u20131998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD. Rev. Esp. Quimioter.13 (4), 379\u2013383 (2000).","journal-title":"Rev. Esp. Quimioter."},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-2-201201170-02010"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2009.12.002"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1159\/000321374"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1666OC"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2012.02135.x"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S33714"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-13-82"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12199"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S38652"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00093913"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.11.001"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.09.2478"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00078-09"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383430"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320319"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01321-8"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-3056"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.10.010"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl270"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.200733"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02042-3"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm084"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00093.2005"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2011.14"},{"key":"e_1_3_3_93_1","unstructured":"Kim IJ Kim H Or YS Wang G: US20090209547 (2009)."},{"key":"e_1_3_3_94_1","unstructured":"Enanta Pharmaceuticals Inc.: WO2010096051 (2010)."},{"key":"e_1_3_3_95_1","unstructured":"Enanta Pharmaceuticals Inc.: WO2008014221 (2008)."},{"key":"e_1_3_3_96_1","unstructured":"PLIVA Inc.: US6369035 (2002)."},{"key":"e_1_3_3_97_1","unstructured":"GlaxoSmithKline Research Centre Zagreb d.o.o.: WO2010086350 (2010)."},{"key":"e_1_3_3_98_1","unstructured":"Rib-X Pharmaceuticals Inc.: WO2008143729 (2009)."},{"key":"e_1_3_3_99_1","unstructured":"Rib-X Pharmaceuticals Inc.: WO2008106224 (2008)."},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.10.061"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.201300266"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.03.076"},{"key":"e_1_3_3_103_1","unstructured":"Catabasis Pharmaceuticals Inc.: WO2011116312 (2011)."},{"key":"e_1_3_3_104_1","unstructured":"PLIVA Inc.: EP0283055 (1989)."},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.12.022"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2008.41"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2006.83"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5550"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00552-3"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00553-5"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1078\/0171-9335-00180"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.03.011"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.06.011"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2012.09.007"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01576.x"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1210655"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3287"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.14.14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:49:05Z","timestamp":1716493745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.14.14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.4155\/fmc.14.14"],"URL":"https:\/\/doi.org\/10.4155\/fmc.14.14","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}